Array Biopharma Archives -

Pfizer has stopped development of a drug to treat cardiomyopathy caused by a rare form of heart disease,

Pfizer takes pipeline blow as it abandons cardiomyopathy drug

https://pharmaphorum.com/news/pfizer-takes-pipeline-blow-as-it-abandons-cardiomyopathy-drug/

A new trial has shown for the first time that a combination of three targeted therapies can improve

Array, Pierre Fabre bowel cancer therapy ‘could replace chemo’

https://pharmaphorum.com/news/array-pierre-fabre-bowel-cancer-therapy-could-replace-chemo/

Pfizer has a made a $48 per share play for Array Biopharma, which values the cancer specialist at

As Lyrica patent expiry looms, Pfizer buys Array for $11.4bn

https://pharmaphorum.com/news/as-lyrica-patent-expiry-looms-pfizer-buys-array-for-11-4bn/

Options for treatment in metastatic melanoma have increased significantly in terms of efficacy and reduction of mortality in

Does NEMO bring us a step closer in the fight against melanoma?

https://pharmaphorum.com/partner-content-oncology/nemo-bring-us-step-closer-fight-melanoma/

Array Biopharma